By Kelly Cloonan
Shares of Phathom Pharmaceuticals fell after the company said Chief Executive Officer Terrie Curran has resigned and will be succeeded by SaNOtize's Steven Basta.
The stock declined 22% to $4.88 on Tuesday, bringing its fall over the last 12 months to 54%.
Phathom said Curran has resigned from her roles as president, CEO and a member of the board for personal reasons.
Basta joins the Florham Park, N.J., biopharmaceutical company as president, CEO and a director, the company said.
Basta previously led SaNOtize, an anti-infective therapies company.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 01, 2025 15:24 ET (19:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。
沒有相關數據
如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”